Key observations from the NHLBI Asthma Clinical Research Network

Stanley J. Szefler, Vernon M. Chinchilli, Elliot Israel, Loren Clark Denlinger, Robert F. Lemanske, William Calhoun, Stephen P. Peters

Research output: Contribution to journalReview article

9 Scopus citations

Abstract

The National Heart, Lung and Blood Institute (NHLBI) Asthma Clinical Research Network (ACRN) recently completed its work after 20 years of collaboration as a multicentre clinical trial network. When formed, its stated mission was to perform multiple controlled clinical trials for treating patients with asthma by dispassionately examining new and existing therapies, and to rapidly communicate its findings to the medical community. The ACRN conducted 15 major clinical trials. In addition, clinical data, manual of operations, protocols and template informed consents from all ACRN trials are available via NHLBI BioLINCC (https://biolincc.nhlbi.nih.gov/studies/). This network contributed major insights into the use of inhaled corticosteroids, short-acting and long-acting β-adrenergic agonists, leukotriene receptor antagonists, and novel agents (tiotropium, colchicine and macrolide antibiotics). They also pioneered studies of the variability in drug response, predictors of treatment response and pharmacogenetics. This review highlights the major research observations from the ACRN that have impacted the current management of asthma.

Original languageEnglish (US)
Pages (from-to)450-455
Number of pages6
JournalThorax
Volume67
Issue number5
DOIs
StatePublished - May 2012

    Fingerprint

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Szefler, S. J., Chinchilli, V. M., Israel, E., Denlinger, L. C., Lemanske, R. F., Calhoun, W., & Peters, S. P. (2012). Key observations from the NHLBI Asthma Clinical Research Network. Thorax, 67(5), 450-455. https://doi.org/10.1136/thoraxjnl-2012-201876